CDH6 and ovarian cancer: In addition to the association between CDH6 and a worse prognosis in ovarian serous carcinoma, αIIbβ3 associated with poor prognosis in clear‐cell and papillary renal carcinomas as well as in ovarian cancer (Fig. S2).